Jean-Louis Imbach

This inventor holds 38 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 3 EPO patents, primarily in Nucleoside Antivirals. Top assignees: Centre National De La Recherche Scientifique, Idenix Pharmaceuticals, Inc., L'université Montpellier Ii. Active years: 1982-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Louis Imbach. Retrieved from https://idiyas.com/inventor/jean-louis-imbach

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 (Patent Applications = 5)

% Patents Active = 81.6

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 19

Forward Citations = 1,662(Granted Patents)

Location History:

Place Eugene Bataillon - 34095 Montpellier, FR (1998)
34000 Montpellier, FR (1984 - 1999)
34095 Montpellier, FR (1997 - 2000)
Montpellier, FR (1982 - 2016)

Company Filing History:

20 out of 5,383

Centre National De La Recherche Scientifique

patents

8 out of 100

Idenix Pharmaceuticals, Inc.

patents

6 out of 13

L'université Montpellier Ii

Commissariat a L'energie Atomique Et Aux Energies Alternatives

patents

6. 2 out of 1,035

Isis Pharmaceuticals, Inc.

patents

7. 2 out of 641

The UAB Research Foundation (The University of Alabama at Birmingham)

patents

8. 1 out of 338

Agence Nationale De Valorisation De La Recherche (Anvar)

The University of Alabama

patents

13. 1 out of 4

University of Montpellier Ii

patents

14. 11 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1982-2016

Loading Chart...

Areas of Expertise:

Nucleosides

Antivirals

Hepatitis B

Hepatitis C

Oligonucleotides

Phosphotriester

3'-Prodrugs

Biologically Active

Cystamine Derivatives

Acyclovir Derivatives

Nitrosoureas

Radioprotective Agents

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9290533 - β-L-2'-deoxy-nucleosides for the treatment of hepatitis B (2016-03-22),

2. 8304532 - Method for preparing oligonucleotides (2012-11-06),

3. 7795238 - β-L-2'-deoxy-nucleosides for the treatment of hepatitis B (2010-09-14),

4. 7585851 - 3'-prodrugs of 2′-deoxy-β-L-nucleosides (2009-09-08),

5. 7468357 - Nucleosides with anti-hepatitis B virus activity (2008-12-23),

6. 7439351 - 2' or 3′ -deoxy and 2′, 3′-dideoxy-β-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti-viral agents (2008-10-21),

7. 7304043 - β-L-2'-deoxy-nucleosides for the treatment of hepatitis B (2007-12-04),

8. 7138376 - Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides (2006-11-21),

9. 6989372 - Antioxidants, preparation methods and uses (2006-01-24),

10. 6979747 - Antioxidants, preparation processes and their uses (2005-12-27),

11. 6946450 - β-L-2'-deoxy-nucleosides for the treatment of hepatitis B (2005-09-20),

12. 6896900 - β-L-2'-deoxy-nucleosides for the treatment of HIV infection (2005-05-24),

13. 6875751 - 3'-prodrugs of 2′-deoxy-β-L-nucleosides (2005-04-05),

14. 6569837 - &bgr;-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis B (2003-05-27),

15. 6566344 - &bgr;-L-2′-deoxy-nucleosides for the treatment of hepatitis B (2003-05-20),

Title: Jean-Louis Imbach - Innovative Inventor from Montpellier

Introduction: Jean-Louis Imbach is a renowned inventor hailing from Montpellier, France, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Jean-Louis Imbach holds several patents in the areas of renewable energy technologies, sustainable agriculture solutions, and advanced medical devices, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over three decades, Jean-Louis Imbach has established himself as a pioneer in the world of inventions, with numerous successful products that have had a significant impact on society.

Collaborations: Throughout his career, Jean-Louis Imbach has collaborated with leading research institutions, universities, and companies to further develop and commercialize his inventions, demonstrating his commitment to driving innovation forward.

Conclusion: Jean-Louis Imbach's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.